Gilead Sciences (GILD) New Drug offers hope for Treatment of COVID-19 – Africa Business and News World – africabusines

Africa Business and News World

Gilead Sciences (GILD) New Drug offers hope for Treatment of COVID-19

New Hope for Cure of Coronavirus
The drug of one Pharmaceutical company Gilead Sciences Wall Street  Trading Symbol (GILD) suddenly gained significantly in Wall Street stock markets last week so I decided to find out why this stock price suddenly took off in price valuation. I asked myself what  Wall Street knows that most investors did not know about GILEAD Sciences. Upon checking, I discovered that Gilead Sciences has been conducting trials for one of its drugs called “Remdesivir”, and the drug showed significant promise for curing Coronavirus.
“Gilead Sciences, Inc., is an American biopharmaceutical company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi”

According to the news Gilead Sciences drug “Remdesivir” had early success in the trials for treatment of Coronavirus.

“Covid-19 patients who are getting the drug, called Remdesivir, have been recovering quickly, with most going home in days”, according to the report.
“The 125 patients in a clinical trial of the drug all had severe respiratory symptoms and fever, but many were able to leave the hospital after less than a week of treatment, STAT NEWS quoted the doctor leading the trial”.
The University of Chicago says it would make an official comment once the official trial result were ready at the end of the month of April. The stock of Gilead Sciences has gained 20% in last 3 days of trading from $71 a share to $83 close on Friday
Africa Business World, (ABW) will report more on this drug when more information becomes available.
Chief Okechukwu P. Oranika Reporting


What’s your opinion?

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »